Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of March 2, 2026, Healthpeak Properties, Inc. (DOC) has a Wall Street consensus price target of $18.33, based on estimates from 40 covering analysts. With the stock currently trading at $17.68, this represents a potential upside of +3.7%. The company has a market capitalization of $12.29B.
Analyst price targets range from a low of $17.00 to a high of $21.00, representing a 22% spread in expectations. The median target of $17.50 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 22 analysts rating the stock as a Buy or Strong Buy,18 rating it Hold, and 0 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, DOC trades at a trailing P/E of 176.8x and forward P/E of 66.6x. Analysts expect EPS to grow +159.0% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $17.68, with bear and bull scenarios of $31.84 and $119.17 respectively. Model confidence stands at 53/100, reflecting moderate uncertainty in projections.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how DOC stacks up against sector leader Welltower Inc..
Start ComparisonThe consensus price target for DOC is $18.33, close to the current price of $17.68 (3.7% implied move). Based on 40 analyst estimates, the stock appears fairly valued near current levels.
DOC has a consensus rating of "Buy" based on 40 Wall Street analysts. The rating breakdown is predominantly bullish, with 22 Buy/Strong Buy ratings. The consensus 12-month price target of $18.33 implies 3.7% upside from current levels.
At a forward P/E of 66.5913x, DOC trades at a premium valuation. The consensus price target of $18.33 (3.7% upside) suggests analysts may view current valuations as stretched.
The most bullish Wall Street analyst has a price target of $21 for DOC, while the most conservative target is $17. The consensus of $18.33 represents the median expectation. Our quantitative valuation model projects a bull case target of $119 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
DOC is heavily covered by Wall Street, with 40 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 22 have Buy ratings, 18 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month DOC stock forecast based on 40 Wall Street analysts shows a consensus price target of $18.33, with estimates ranging from $17 (bear case) to $21 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $18, with bear/bull scenarios of $32/$119.
Our quantitative valuation model calculates DOC's fair value at $18 (base case), with a bear case of $32 and bull case of $119. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 53/100.
DOC trades at a forward P/E ratio of 66.6x based on next-twelve-months earnings estimates compared to a trailing P/E of 176.8x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
DOC appears fairly valued according to analysts, with a "Buy" rating and minimal upside to the $18.33 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
DOC analyst price targets range from $17 to $21, a 22% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $18.33 consensus represents the middle ground. Our model's $32-$119 range provides an independent fundamental perspective.